Prospective observational multicenter study of patients with Arterial hypertension and chronic kidney disease markers in Kazakhstan (PROGRESS-CKD) - D1843R00359

Study identifier:D1843R00359

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

Prospective observational multicenter study of patients with Arterial hypertension and chronic kidney disease markers in Kazakhstan (PROGRESS-CKD)

Medical condition

To describe the rate of CKD diagnosis in patients with hypertension and CKD markers

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1282

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 27 Dec 2024
Estimated Primary Completion Date: 30 Apr 2026
Estimated Study Completion Date: 30 Apr 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria